Corporacion Ecuatoriana de Biotecnologia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2000
NCT00228254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

vitamin a (1 trial)

zn2+ (1 trial)

Drugs in Other Trials (2)

multivitamins (1 trial)

zinc dichloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 4)

Infections (Phase 4)

Pneumonia (Phase 4)

Respiratory Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4